Medical comms - Press Releases

Date	Title	Company
22-Jul-2020	Biotech company raises £2.25m for new spinal treatments	Locate Bio
22-Jul-2020	UCLB and Apollo Therapeutics secure first out-licensing deal to Deerfield, a leading U.S. healthcare investment firm	UCL Business
22-Jul-2020	UNION therapeutics announces acquisition of PDE4i compound class from LEO Pharma with oral lead candidate (orismilast) in Phase 2	UNION therapeutics A/S
22-Jul-2020	Ergomed H1 2020 Trading Update	Ergomed plc
22-Jul-2020	Algenex and Global DX Announce Positive Evaluation of Herdscreen® ASFV Antibody Test for African Swine Fever	Algenex SL
22-Jul-2020	Largest clinical study of its type shows Kaia back pain app outperforms standard-of-care treatment across all medical outcomes	Kaia Health
22-Jul-2020	Novel Platforms in Ocular Drug Delivery workshop discussed at Ophthalmic Drugs	SMi Ltd
20-Jul-2020	Oxford Biomedica notes interim results from AstraZeneca on AZD1222 showing strong antibody and T-cell responses and acceptable safety profile	Oxford Biomedica plc
20-Jul-2020	Tiziana Life Sciences plc Director Appointment	Tiziana Life Sciences plc
20-Jul-2020	Synairgen announces positive results from trial of SNG001 in hospitalised COVID-19 patients	Synairgen plc
20-Jul-2020	Phlexglobal and Arkivum join forces to enable Trial Master File data compliance over its entire extended lifecycle	Arkivum
20-Jul-2020	Campaigners warn that the government is racing ahead with vaccine nationalism	Pfizer
20-Jul-2020	Acumentice expands senior team with Purdy appointment	Acumentice
20-Jul-2020	Polyplus-transfection launches a residual test for its transfection reagent products for ATMP sector	Polyplus-transfection
20-Jul-2020	Annual Review 2020 highlights impact on growth and productivity in the UK cell and gene therapy industry	Cell and Gene Therapy Catapult
20-Jul-2020	British Patient Capital commits $65m to SV Health Investors, to invest in life-changing biotechnology companies	SV Health Investors
20-Jul-2020	AMRYT TO ANNOUNCE Q2 RESULTS ON AUGUST 6, 2020	Amryt
20-Jul-2020	BERGENBIO ANNOUNCES FIRST PATIENT DOSED IN RECURRENT GLIOBLASTOMA INVESTIGATOR SPONSORED PHASE I/II STUDY ASSESSING SELECTIVE AXL INHIBITOR BEMCENTINIB	BerGenBio ASA
20-Jul-2020	Santhera to Join SIX Swiss Exchange Life Science Industry Indices	Santhera Pharmaceuticals
20-Jul-2020	Pfizer and BioNTech Announce Agreement with the United Kingdom for 30 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2	BioNTech